We are live on ! Find out more
DCLA

Douglas C. Lane & Associates Portfolio holdings

AUM $3.69B
1-Year Est. Return 0.11%
This Fund
S&P 500
This Quarter Est. Return
+8.1%
1 Year Est. Return
+0.11%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.7B
AUM Growth
+$353M
Cap. Flow
+$108M
Cap. Flow %
2.9%
Top 10 Hldgs %
21.6%
Holding
250
New
17
Increased
88
Reduced
111
Closed
12

Top Buys

Rank Stock Value
1
SSYS icon
Stratasys
SSYS
+$34.7M
2
ABCO
Advisory Board Co
ABCO
+$12M
3
MET icon
MetLife
MET
+$11.9M
4
MANH icon
Manhattan Associates
MANH
+$10.2M
5
PINC
Premier
PINC
+$6.5M

Top Sells

Rank Stock Value
1
GEN icon
Gen Digital
GEN
+$14M
2
LUX
Luxottica Group
LUX
+$5.85M
3
UN
Unilever NV New York Registry Shares
UN
+$4.45M
4
XRAY icon
Dentsply Sirona
XRAY
+$4.32M
5
KO icon
Coca-Cola
KO
+$3.87M

Sector Composition

Rank Sector Weight
1 Industrials 21.15%
2 Technology 15.87%
3 Healthcare 14.75%
4 Consumer Discretionary 11.03%
5 Financials 6.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QVCGA
201
DELISTED
QVC Group Inc Series A
QVCGA
$263K 0.01%
+184
New +$242K
IP icon
202
International Paper
IP
$22.1B
$251K 0.01%
4,957
-190
-4% -$9.3K
TGT icon
203
Target
TGT
$67.5B
$250K 0.01%
3,297
-235
-7% -$15.9K
MLM icon
204
Martin Marietta Materials
MLM
$33B
$243K 0.01%
2,201
+91
+4% +$10.8K
WMT icon
205
Walmart Inc
WMT
$886B
$241K 0.01%
+8,433
New +$228K
NJR icon
206
New Jersey Resources
NJR
$5.57B
$240K 0.01%
+7,842
New +$223K
DUK icon
207
Duke Energy
DUK
$97.5B
$234K 0.01%
2,799
-602
-18% -$48.5K
BXP icon
208
Boston Properties
BXP
$11.1B
$232K 0.01%
1,800
-30
-2% -$3.8K
HSBC icon
209
HSBC
HSBC
$355B
$229K 0.01%
5,635
-64,675
-92% -$2.76M
D icon
210
Dominion Energy
D
$59.4B
$227K 0.01%
2,952
– –
LLY icon
211
Eli Lilly
LLY
$1.05T
$227K 0.01%
3,292
+30
+0.9% +$2.02K
HCA icon
212
HCA Healthcare
HCA
$89.3B
$220K 0.01%
3,000
– –
MDP
213
DELISTED
Meredith Corporation
MDP
$217K 0.01%
+4,000
New +$200K
TFC icon
214
Truist Financial
TFC
$64.1B
$216K 0.01%
5,550
-174
-3% -$6.55K
SCHW
215
Charles Schwab
SCHW
$186B
$214K 0.01%
7,092
+18
+0.3% +$511
CLX icon
216
Clorox
CLX
$12.8B
$209K 0.01%
2,002
-125
-6% -$12.5K
WBA
217
DELISTED
Walgreens Boots Alliance
WBA
$205K 0.01%
+2,692
New +$180K
VTRS icon
218
Viatris
VTRS
$19.3B
$202K 0.01%
+3,575
New +$192K
MJN
219
DELISTED
Mead Johnson Nutrition Company
MJN
$201K 0.01%
+2,000
New +$199K
WNEB icon
220
Western New England Bancorp
WNEB
$276M
$198K 0.01%
27,000
– –
ESRT icon
221
Empire State Realty Trust
ESRT
$836M
$195K 0.01%
+11,087
New +$181K
HBAN icon
222
Huntington Bancshares
HBAN
$35.4B
$195K 0.01%
18,535
– –
KEY icon
223
KeyCorp
KEY
$24.4B
$195K 0.01%
14,000
– –
JBLU icon
224
JetBlue
JBLU
$2.26B
$161K ﹤0.01%
10,150
– –
FULT icon
225
Fulton Financial
FULT
$4.65B
$135K ﹤0.01%
10,950
– –
6 7 8
9
10

Similar funds

AM
Appaloosa Management Miami Beach, Florida $5.01B AUM 0.22% 1-Year Est. Return
NRECA
National Rural Electric Cooperative Association Arlington, Virginia $5.58B AUM 0.17% 1-Year Est. Return
ALA
Atherton Lane Advisers Menlo Park, California $1.72B AUM 0.32% 1-Year Est. Return
KIG
Kovitz Investment Group Chicago, Illinois $1.62B AUM 5.44% 1-Year Est. Return
GC
GW Capital Bellevue, Washington $1.44B AUM 5.7% 1-Year Est. Return
CC
Curian Capital Denver, Colorado $1.35B AUM 0.33% 1-Year Est. Return
CC
Chubb Corp Warren, New Jersey $1.24B AUM 0.59% 1-Year Est. Return
AC
Apex Capital Orinda, California $938M AUM 4.67% 1-Year Est. Return

Douglas C. Lane & Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Douglas C. Lane & Associates held 250 positions worth $3.7B, up 11% from $3.35B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Douglas C. Lane & Associates's Q4 2014 filing shows 17 new, 88 increased, 111 reduced and 12 closed positions. Its largest new stake was Manhattan Associates: 267,887 shares worth $10.9M. The largest sale was Gen Digital, an estimated $14M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

  • Douglas C. Lane & Associates's largest Q4 2014 buy was Manhattan Associates: 267,887 shares worth $10.9M.
  • Douglas C. Lane & Associates added most to Stratasys in Q4 2014, an estimated $34.7M increase.
  • Douglas C. Lane & Associates's biggest Q4 2014 reduction was Gen Digital, cutting an estimated $14M.
  • Douglas C. Lane & Associates fully exited Baxter International in Q4 2014, selling an estimated $343K.
  • Douglas C. Lane & Associates's ten largest holdings make up 22% of its $3.7B portfolio in Q4 2014.
  • Douglas C. Lane & Associates opened 17 new positions and closed 12 in Q4 2014.
  • Douglas C. Lane & Associates's portfolio value rose 11% quarter-over-quarter to $3.7B.

Based on Douglas C. Lane & Associates's 13F filing for Q4 2014, filed 21 Jan 2015.